Collegium Pharmaceutical Inc is a US-based specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing and dissolving. The company's product Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone.
| Website: | www.collegiumpharma.com |
| Email: | info@collegiumpharma.com |
| Main Phone: | +1 781 713-3699 |
| Address: | 100 Technology Center Drive |
| Address 2: | Suite 800 |
| State: | MA |
| City / Town: | Stoughton |
| Country: | USA |
| Postal Code: | 02072 |
| Exchange: | NGS |
| CEO: | Joseph J. Ciaffoni |
| Employees: | 266 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Gathering Data... Please wait Collegium Pharmaceutical Inc is a US-based specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing and dissolving. The company's product Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone.
| Website: | www.collegiumpharma.com |
| Email: | info@collegiumpharma.com |
| Main Phone: | +1 781 713-3699 |
| Address: | 100 Technology Center Drive |
| Address 2: | Suite 800 |
| State: | MA |
| City / Town: | Stoughton |
| Country: | USA |
| Postal Code: | 02072 |
| Exchange: | NGS |
| CEO: | Joseph J. Ciaffoni |
| Employees: | 266 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 12.15 | Change $ -0.29 | Change % -2.33 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask 16.95 | Ask Size 500.00 |
| Open 12.72 | High 12.89 | Low 12.05 | Prev Close 12.44 |
| Last Trade | Volume 314,801 | 52 Wk Hi 19.83 | 52 Wk Low 10.01 |
| Market Cap 406.7 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 33,470,530.00 | EPS (TTM) -0.66 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 21 | 56 |
| Number of Buys | 12 | 27 |
| Number of Sells | 9 | 29 |
| Net Activity | -619863 | -3336202 |
| Last 10 Buys | Shares |
|---|---|
| Paul Brannelly | 1,000 |
| John A. Fallon | 1,000 |
| Patrick G. Enright | 1,000 |
| Alan D. Frazier | 1,000 |
| Patrick J. Heron | 1,000 |
| David Hirsch | 1,000 |
| David Hirsch | 1,000 |
| John G. Freund | 1,000 |
| James G. Coulter | 1,000 |
| Patrick G. Enright | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Joseph Ciaffoni | 1,000 |
| Joseph Ciaffoni | 1,000 |
| Joseph Ciaffoni | 1,000 |
| Michael Heffernan | 1,000 |
| Michael Heffernan | 1,000 |
| Michael Heffernan | 1,000 |
| Michael Heffernan | 1,000 |
| Michael Heffernan | 1,000 |
| Michael Heffernan | 1,000 |
| Alison B. Fleming | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 35 | 35 | 35 | 35 |
| Low Target Price Estimate | 27 | 27 | 27 | 27 |
| Mean Target Price Estimate | 32.2 | 32.2 | 32.2 | 32.2 |
| Standard Deviation | 3.11 | 3.11 | 3.11 | 3.11 |
| Date of Most Recent Estimate | 06/05/18 | 05/10/18 | 05/10/18 | 06/05/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| S-8 | Securities offered to employees under employee benefit plans | 8 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-04 |
| 8-K | Report of unscheduled material events or corporate changes. | 11 | 2018-06-04 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-29 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-29 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-29 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-29 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-29 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 |
| Moderate Buy | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1.14 | 1.14 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
